• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168

tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate (CAS No. 1638767-25-5): A Comprehensive Overview

tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate (CAS No. 1638767-25-5) is a unique and versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as TBUC-BAPC, is characterized by its distinctive bicyclo[1.1.1]pentane core, which imparts unique structural and chemical properties that make it a valuable scaffold for the development of novel therapeutics.

The bicyclo[1.1.1]pentane moiety, a three-carbon bridge with two additional carbon atoms forming a cage-like structure, has been the focus of extensive research due to its potential to enhance the pharmacological properties of drug candidates. The presence of this rigid and highly constrained ring system can significantly influence the conformational flexibility, lipophilicity, and metabolic stability of molecules, thereby improving their bioavailability and pharmacokinetic profiles.

TBUC-BAPC is particularly interesting due to its amino functional group, which can be readily modified to introduce various substituents, thereby expanding its utility in drug discovery and development. The tert-butyl carbamate group, on the other hand, serves as a protecting group for the amino functionality, allowing for controlled deprotection and subsequent derivatization in synthetic pathways.

Recent studies have highlighted the potential of tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate in the development of central nervous system (CNS) therapeutics. For instance, a 2022 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of TBUC-BAPC exhibited potent activity against neurodegenerative diseases such as Alzheimer's and Parkinson's disease. The unique structure of TBUC-BAPC allowed for enhanced blood-brain barrier penetration and improved target engagement, making it a promising lead compound for further optimization.

In addition to its potential in CNS disorders, tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate has also shown promise in oncology research. A 2023 study in the European Journal of Medicinal Chemistry reported that certain derivatives of TBUC-BAPC exhibited selective cytotoxicity against various cancer cell lines, including those resistant to conventional chemotherapy agents. The rigid structure of the bicyclo[1.1.1]pentane core was found to enhance the stability and specificity of these compounds, potentially leading to more effective and targeted cancer therapies.

The synthetic accessibility of tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate is another key factor contributing to its widespread use in medicinal chemistry research. Several efficient synthetic routes have been developed to prepare this compound, including those involving palladium-catalyzed cross-coupling reactions and organocatalytic methods. These synthetic strategies not only facilitate the preparation of TBUC-BAPC but also enable the rapid generation of diverse analogs for structure-activity relationship (SAR) studies.

The pharmacological properties of tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate have been extensively evaluated in preclinical models, with promising results observed across multiple therapeutic areas. For example, in vitro assays have shown that TBUC-BAPC derivatives exhibit high potency against specific protein targets involved in inflammation and pain signaling pathways, suggesting potential applications in the treatment of chronic inflammatory conditions.

Clinical trials are currently underway to further investigate the safety and efficacy of tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate derivatives in human subjects. Early-phase trials have demonstrated favorable pharmacokinetic profiles and acceptable safety margins, paving the way for more advanced clinical studies.

In conclusion, tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate (CAS No. 1638767-25-5) represents a promising scaffold for the development of novel therapeutics across various disease areas. Its unique structural features, coupled with its synthetic accessibility and favorable pharmacological properties, make it an attractive candidate for further exploration in medicinal chemistry and pharmaceutical research.

• 372963-43-4(tert-Butyl N-3-Aminoadamant-1-ylcarbamate)
• 1461706-82-0(tert-butyl N-(5-aminonorpinan-1-yl)carbamate;hydrochloride)
• 1050890-47-5(tert-butyl N-(4-amino-1-bicyclo[2.1.1]hexanyl)carbamate)
• 886362-50-1(tert-butyl N-1-(2-aminoethyl)cyclohexylcarbamate)
• 1408074-61-2(tert-butyl trans-N-(3-amino-1-methyl-cyclobutyl)carbamate)
• 1408076-24-3(tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate)
• 1408075-91-1(tert-butyl trans-N-(3-amino-3-methyl-cyclobutyl)carbamate)
• 1895535-27-9(tert-Butyl N-[1-(2-aminoethyl)cyclobutyl]carbamate)
• 1049607-15-9(tert-butyl N-(5-aminonorpinan-1-yl)carbamate)
• 1408076-04-9(tert-butyl cis-N-(3-amino-1-methyl-cyclobutyl)carbamate)